Cheng Chen

机构：Guangzhou University of Chinese Medicine, Chongqing University, Solvay (Belgium), Shenzhen University, Zunyi Medical University, Sichuan University, Jiangsu Cancer Hospital, The First People’s Hospital of Lianyungang, Shenzhen Technology University, First People's Hospital of Chongqing, UCLouvain · ORCID：0000-0002-9057-1952

发表论文 87 篇 · 总被引 1577 次 · h-index 25

代表论文

• LIFU-unlocked endogenous H2S generation for enhancing atherosclerosis-specific gas-enzymatic therapy (2024 · Biomaterials · 被引 20)
• An in situ bioadhesive foam as a large intestinal delivery platform for antibody fragment to treat inflammatory bowel disease (2024 · Journal of Controlled Release · 被引 12)
• Oral Lipid-Based Nanomedicine for the Inhibition of the cGAS-STING Pathway in Inflammatory Bowel Disease Treatment (2025 · Molecular Pharmaceutics · 被引 11)
• Deep Learning and Radiomics in Triple-Negative Breast Cancer: Predicting Long-Term Prognosis and Clinical Outcomes (2025 · Journal of Multidisciplinary Healthcare · 被引 9)
• A Multicenter, Randomized, Double-Blind, Parallel-Grouped, Positive-Controlled, Non-Inferiority Clinical Study to Evaluate the Efficacy and Safety of Injectable Calcium Hydroxylapatite Microsphere Hydrogel Fillers in the Correction of Nasolabial Fold in Chinese Subjects (2024 · Aesthetic Plastic Surgery · 被引 8)
• Advanced oral therapies for colorectal cancer via nanomedicine and microbiota modulation (2025 · Advanced Drug Delivery Reviews · 被引 6)